COVID-19: Is There Evidence for the Use of Herbal Medicines as Adjuvant Symptomatic Therapy?

Background Current recommendations for the self-management of SARS-Cov-2 disease (COVID-19) include self-isolation, rest, hydration, and the use of NSAID in case of high fever only. It is expected that many patients will add other symptomatic/adjuvant treatments, such as herbal medicines. Aims To pr...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Frontiers in pharmacology 2020-09, Vol.11, p.581840-581840, Article 581840
Hauptverfasser:	Silveira, Damaris, Prieto-Garcia, Jose Maria, Boylan, Fabio, Estrada, Omar, Fonseca-Bazzo, Yris Maria, Jamal, Claudia Masrouah, Magalhaes, Perola Oliveira, Pereira, Edson Oliveira, Tomczyk, Michal, Heinrich, Michael
Format:	Artikel
Sprache:	eng
Schlagworte:	benefit/risk assessment coronavirus (2019-nCoV) COVID-19 herbal medicine Life Sciences & Biomedicine Pharmacology Pharmacology & Pharmacy respiratory diseases Science & Technology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!